Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Guarana

Phase 2Small molecule

UUniversity of Utah

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q3 2028

Phase 2Recruiting

Fatigue

NCT07151391

Clinical

Trials by Indication[1]

Fatigue1 trial

The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)

Recruiting·UUniversity of Utah·Phase 2·NCT07151391·86 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Guarana. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Guarana compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Guarana. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Utah company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: UUniversity of Utah

Related News